Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Baylor University Me...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Baylor University Medical Center Proceedings
Article . 2012 . Peer-reviewed
Data sources: Crossref
versions View all 2 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

Chordoid Glioma of the Third Ventricle

Authors: Mehrzad, Zarghouni; Clayton, Vandergriff; Kennith F, Layton; J Brad, McGowan; Caetano, Coimbra; Amol, Bhakti; Michael J, Opatowsky;

Chordoid Glioma of the Third Ventricle

Abstract

A chordoid glioma is a rare low-grade tumor that arises from the anterior wall or roof of the third ventricle. It is postulated that this tumor originates from the ependymal cells of lamina terminalis (1). These slowly growing tumors are more common in females and are predominantly seen in the adult population. Most commonly, this tumor presents with clinical signs and symptoms of obstructive hydrocephalus to include nausea and headache (2), although endocrine imbalances, visual disturbances, and dysautonomia have also been reported. The best imaging diagnostic tool for evaluation of chordoid gliomas is magnetic resonance imaging (MRI) of the brain with gadolinium. Typically, these tumors are well circumscribed, round or oval in shape, with T2 images showing iso- to hyperintense third-ventricle masses with avid homogenous enhancement (2) (Figure ​(Figure11). Cystic changes are infrequently seen within the periphery of these tumors (3). On computed tomography (CT) scans, a chordoid glioma presents as a hyperattenuating mass arising from the third ventricle that homogeneously enhances following contrast administration (Figure ​(Figure22). Figure 1 MRI images of chordoid glioma. (a) T2 axial, (b) postgadolinium T1 axial, (c) postgadolinium T1 coronal, and (d) T1 sagittal MRI images show a multilobulated homogeneously enhancing mass centered within the region of the anteroinferior third ventricle ... Figure 2 CT images of chordoid glioma. (a) Precontrast and (b) postcontrast CT images reveal an enhancing mass arising from the inferior recess of the third ventricle (arrow). Differential considerations for an anterior third ventricle mass in an adult include a colloid cyst, germinoma, ependymoma, macroadenoma, and chordoid glioma. A colloid cyst is predominantly a nonenhancing cystic lesion located at the foramen of Monro. Ependymomas usually extend into the third ventricle centered at the foramen of Monro. Macroadenomas are enhancing masses involving the pituitary gland. Germinomas also arise from the pituitary stalk. Therefore, based on the imaging characteristics of this lesion, a chordoid glioma is favored. Complete surgical resection is considered the treatment of choice for these neoplasms. The deep anatomic location of these tumors places the patient at increased risk of surgical morbidity and mortality. Although the neoplasm is low grade, incompletely resected tumors will continue slowly growing and may require later re-resection with the possibility of poorer clinical outcomes (3). Our patient initially presented with symptoms of visual disturbance, endocrinopathy, and pituitary dysfunction. Following surgical resection and stereotactic radiosurgery, the patient experienced improvement in vision, an unchanged endocrinopathy, and no newly acquired pituitary dysfunction.

Related Organizations
  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    11
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Top 10%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
11
Average
Top 10%
Average
gold